Tumor necrosis factor-alpha in pediatric HIV-1 infection.

Tumor necrosis factor alpha in mycobacterial infection.

Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery.

macrophage infection by HIV1.

Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review.

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages.

Tumor necrosis factor-alpha.

Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice.

Association between HIV1 infection and sexually transmitted disease among men in Central Africa.

Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection.

Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans.

Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors.

Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-alpha.

A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection.

Serum tumor necrosis factor-alpha concentrations in children hospitalized for acute lower respiratory tract infection.

Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection.

Tumor necrosis factor and interferon as prognostic markers in human immunodeficiency virus (HIV) infection.

Tuberculosis infection versus anti-tumor necrosis factor therapy: screening challenges in psoriatic patients.

Infection of monocytic cells by HIV1: combined role of FcR and CD4.

Imaging Tumor Necrosis with Ferumoxytol.

Tumor necrosis and cell detachment.

Tumor necrosis factor and hypermetabolism.

Tumor necrosis factor-alpha in human milk.

Tumor necrosis factor in human disease.

Suggest Documents

Tumor necrosis factor alpha in mycobacterial infection.

Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery.

macrophage infection by HIV1.

Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review.

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.

Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages.

Tumor necrosis factor-alpha.

Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice.

Association between HIV1 infection and sexually transmitted disease among men in Central Africa.

Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection.

Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans.

Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors.

Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-alpha.

A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection.

Serum tumor necrosis factor-alpha concentrations in children hospitalized for acute lower respiratory tract infection.

Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection.

Tumor necrosis factor and interferon as prognostic markers in human immunodeficiency virus (HIV) infection.

Tuberculosis infection versus anti-tumor necrosis factor therapy: screening challenges in psoriatic patients.

Infection of monocytic cells by HIV1: combined role of FcR and CD4.

Imaging Tumor Necrosis with Ferumoxytol.

Tumor necrosis and cell detachment.

Tumor necrosis factor and hypermetabolism.

Tumor necrosis factor-alpha in human milk.

Tumor necrosis factor in human disease.

Tumor necrosis factor-alpha in pediatric HIV-1 infection.

Recommend Documents

Follow Us